Загрузка...
Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients
OBJECTIVE: Fingolimod is approved for the treatment of highly active relapsing remitting multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine-1-phosphate receptor-modulation. Although fingolimod-associated lymphopenia is a well-known phenomenon, the exact cause...
Сохранить в:
| Опубликовано в: : | Front Immunol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256977/ https://ncbi.nlm.nih.gov/pubmed/30524432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02669 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|